Lanvis
Lanvis is a medicine authorised by Swissmedic under authorisation number 37890. The authorisation holder is Aspen Pharma Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 01 June 1973 and the authorisation is valid without a time limit. ATC code L01BB03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 37890 |
|---|---|
| Name | Lanvis |
| Full name | Lanvis, Tabletten |
| Authorisation holder | Aspen Pharma Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01BB03 |
| First authorisation | 01 June 1973 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lanvis, Tabletten | A | 01 June 1973 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 14 | 25 | Tablette(n) | L01BB03 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Lanvis authorised in Switzerland?
Yes. Lanvis is authorised by Swissmedic under authorisation number 37890, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lanvis have?
Lanvis is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Lanvis?
The authorisation holder is Aspen Pharma Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.